ImaginAb logo

ImaginAb

ImaginAb is an immune and oncology imaging company developing a pipeline of novel products that give physicians unprecedented insights into the patient's health--enabling better patient selection and treatment monitoring for immuno-oncology therapies and other drugs.

2

Funding Rounds

$20.5m

Money raised

Overview

ImaginAb is an immune and oncology imaging company developing a pipeline of novel products that give physicians unprecedented insights into the patient's health--enabling better patient selection and treatment monitoring for immuno-oncology therapies and other drugs.

Funding series

Funding Series Analysis

The company ImaginAb has raised a total of $12.5m in funding over 2 rounds.

Key Insights:

  • ImaginAb Series A round: $12.5m
  • ImaginAb funding round, October 2017: $8m
ImaginAb logo
ImaginAb Series A round $12.5m
ImaginAb logo
ImaginAb funding round, October 2017 $8m